General Information and Statistics

2001 ◽  
Vol 05 (20) ◽  
pp. 514-519

Singapore Aims to be Regional Hub for Biomedical Research. Infant Mortality Rate Down in China. China's First Breast Cancer Treatment Center Established. Singapore Hunts for CEO of Biomedical Fund from Private Sector. Western China to Set Up Embryonic Transplantation Training Center. Appetite Pill Abused in Thailand. Taiwan Patents 41 Biochip Technology. NZ Science Minister to Promote Biotech in Singapore. Korea to Invest Heavily in Health Industry. Mad-Cow Disease Reported in Japan. Australia's CSIRO Ranked Top Five in the World.

2015 ◽  
Vol 29 (S1) ◽  
Author(s):  
Patricia Di Pietro ◽  
Thaiany Piazera Fanni Bavaresco ◽  
Rafaela Santos ◽  
Sheyla Liz ◽  
Alyne Cardoso ◽  
...  

Author(s):  
Nawfal Alrawi

Cancer is one of the most common diseases around the world and the second leading cause of death after cardiovascular disease. Breast cancer is the most prevalent cancer type among Iraqi women, as it represents the highest percentage of malignant tumors in women until 2018. Therefore, women should be aware of the aggravation of this disease, the importance of the periodic examination for early detection for breast cancer, and following the most appropriate means for the treatment to get recovered and, thus, to reduce mortality. To fight cancer, there is an urgent need to search for new effective anticancer therapies that alter the molecular biology of tumor cells, stimulate the immune system, or specifically deliver chemotherapy factors directly to cancer cells without affecting normal cells and reducing the side effects of treatments. In this context, this paper aimed to highlight the therapeutic approaches used in the current researches of breast cancer treatment. Accumulated evidence showed that medicinal plant extracts, and can serve as anticancer agents. The proposed mechanisms were discussed and presented in this review.


2004 ◽  
Vol 22 (15) ◽  
pp. 3091-3098 ◽  
Author(s):  
Nancy K. Janz ◽  
Patricia A. Wren ◽  
Laurel A. Copeland ◽  
Julie C. Lowery ◽  
Sherry L. Goldfarb ◽  
...  

Purpose This study explored patient preferences for involvement in the breast cancer treatment decision and concordance between patients' and physicians' views on decisional role. The impact of demographic and psychosocial characteristics on patients' decisional role was also examined. Patients and Methods Women with stage I or II breast cancer who were candidates for either mastectomy or lumpectomy were recruited from a university breast cancer treatment center. Patient interviews were obtained before meeting the surgical oncologist and again after the treatment decision was made but before surgical intervention. Clinician responses were obtained after the consultation. Results The 101 participants were generally white (97%), married (80%), and well-educated. They reported moderate levels of depression and anxiety but good social support and self-efficacy in communicating with their physician. Before the consultation, 47% of women reported a preference for shared decision making; afterwards, 61% felt they had primary responsibility for the decision. Only 38% of patients agreed with the physician's assessment of how the treatment decision was made. In regression analyses, higher education was significantly associated with patients' preferred level of control (P = .01). There was a trend toward women with greater self-efficacy desiring more active decisional roles (P = .08). Patient preference for decision making did not impact time in the patient-physician encounter, but more influence did increase satisfaction. Conclusion Limited concordance between patient preference and patient perception and between patient and physician perception in how the treatment decision was made suggests the need for better communication between patient and clinician during a critical treatment encounter for breast cancer patients.


Sign in / Sign up

Export Citation Format

Share Document